|Year : 2017 | Volume
| Issue : 4 | Page : 163-167
Improved diagnostic potential of polymerase chain reaction by amplification of multiple gene targets in osteoarticular tuberculosis
Gopinath Palanisamy1, Sameer Aggarwal1, Kusum Sharma2, Balaji Saibaba1, Mandeep Singh Dhillon1
1 Department of Orthopaedics, Post Graduate Institute of Medical Education and Research, Chandigarh, India
2 Department of Microbiology, Post Graduate Institute of Medical Education and Research, Chandigarh, India
|Date of Submission||08-Nov-2016|
|Date of Decision||17-Mar-2017|
|Date of Acceptance||13-Jun-2017|
|Date of Web Publication||23-Aug-2017|
Department of Orthopaedics, Post Graduate Institute of Medical Education and Research, Chandigarh - 160 012
Source of Support: None, Conflict of Interest: None
Purpose: Till date, a number of primers have been described for the diagnostic polymerase chain reaction (PCR) assays for tuberculosis (TB). However, most investigators have evaluated PCR's clinical utility using only one primer specific for Mycobacterium tuberculosis. The purpose of this study was to evaluate the efficacy of PCR tests targeting two different DNA sequences – insertion sequence 6110 (IS6110) and protein antigen b (Pab), in the same set of clinical samples from osteoarticular TB cases, and to evaluate if the sensitivity of the assay is improved. Materials and Methods: Twenty clinical samples obtained from osteoarticular TB cases were subjected to two different PCR assays - 123 base pair (bp) sequence coding for IS6110 and 419 bp sequence coding for Pab. Ten clinical samples from cases of proven septic arthritis were studied as controls. Results: The sensitivity of IS6110 PCR and Pab PCR were found to be 75% and 80%, respectively, and the specificity of both IS6110 PCR and Pab PCR was 100%. No significant difference was found between two PCR assays (P > 0.05). However, there were two cases which were negative by IS6110 PCR but were positive by Pab PCR. There was one case which was positive by IS6110 but was negative by Pab PCR. Seventeen out of 20 samples showed concordance between the results of two PCR tests, increasing the sensitivity to 85%. Conclusion: The diagnostic yield of the PCR test can be improved with the simultaneous amplification of two or more gene targets.
Keywords: Polymerase chain reaction, tuberculosis, osteoarticular
|How to cite this article:|
Palanisamy G, Aggarwal S, Sharma K, Saibaba B, Dhillon MS. Improved diagnostic potential of polymerase chain reaction by amplification of multiple gene targets in osteoarticular tuberculosis. J Med Sci 2017;37:163-7
|How to cite this URL:|
Palanisamy G, Aggarwal S, Sharma K, Saibaba B, Dhillon MS. Improved diagnostic potential of polymerase chain reaction by amplification of multiple gene targets in osteoarticular tuberculosis. J Med Sci [serial online] 2017 [cited 2022 Oct 7];37:163-7. Available from: https://www.jmedscindmc.com/text.asp?2017/37/4/163/213577
| Introduction|| |
Various gene targets have been employed in the diagnostic polymerase chain reaction (PCR) assays for tuberculosis (TB). Most of the past studies have targeted insertion sequence 6110 (IS6110) sequence. However, total absence or presence of only one copy of this sequence has been reported in some clinical isolates.,, Another nucleotide sequence coding for protein antigen b (Pab) specific for Mycobacterium tuberculosis (M. tb) complex has been shown to be a useful target in a few studies. The aim was to evaluate the efficacy of PCR assays targeting two different M. tb specific DNA sequences (IS6110 and Pab) in osteoarticular TB cases, with the intention of improving the diagnostic accuracy.
| Materials and Methods|| |
A prospective study was conducted between July 2013 and December 2014 in our tertiary care health center. The study included two groups: In Group 1 (case group) – Twenty clinical samples were obtained from patients with a strong clinical/radiological/histopathological evidence of TB, including a documented clinical response to antitubercular treatment. These criteria were used as a gold standard, and these were proven cases of tubercular infection. Group 2 (control group) – Ten clinical samples were obtained from patients with the features of septic arthritis with proven bacteriological culture and no evidence of TB. Clinical specimens were collected by arthrocentesis, abscess puncture for pus, curetting for exudation in the sinus, core needle biopsy/open biopsy or fine-needle aspirate (computed tomography-guided/ultrasonography-guided), ensuring strict aseptic precautions.
All pus samples were decontaminated with 4% sodium hydroxide for 10 min and then centrifuged at 6000 rpm for 20 min. The supernatant was discarded and an equal amount of phosphate buffer was added to the sediment. Tissue samples were homogenenized in pestle and mortar, centrifuged at 6000 rpm for 10 min and 3 ml of Tris buffer was added to the pellet. Synovial fluid samples were centrifuged at 6000 rpm for 10 min and 3 ml of Tris buffer was added to the pellet. DNA was extracted using commercially available QIAGEN DNA extraction kit (QIAGEN GmbH, Hilden, Germany) with one initial modification step of keeping the preliminary processed materials at 80°C for 10 min for inactivation of possible mycobacteria. The material was then processed as per the guidelines of the manufacturer of the kit to obtain the DNA.
Polymerase chain reaction for protein antigen b
The primers used to amplify a 419 base pair (bp) sequence coding for the Pab 38 kDa antigen were
- Forward primer Pabf: 5'-ACCACCGAGCGGTTCGC CTGA-3'
- Reversed primer Pabr: 5'-GATCTGCGGGTC GTCCCAGGT-3'.
Polymerase chain reaction for insertion sequence 6110
DNA amplification of the 123 bp IS6110 insertion element was carried out by two oligonucleotide primers sequence, as follows
- Forward primer IS6110f 5'-CCT GCG AGC GTA GGC GTC GG-3'
- Reversed primer IS6110r 5'-CTC GTC CAG CGC CGC TTC GG-3'.
In each independent PCR assay, the test result was compared with the results for one positive and one negative control. The positive control was the DNA of H37 RV strain and negative control was double distilled water. After DNA amplification, the samples were run on 1.5% agarose gel electrophoresis stained with ethidium bromide. The stained gel was examined under ultraviolet light to look for the DNA bands of 419 bp and 123 bp using 100 bp DNA ladder.
| Results|| |
The clinical samples from the study cases (n = 20) included synovial fluid (n = 6), fine-needle aspirate (n = 6), pus (n = 2), core needle biopsy (n = 5), and open biopsy (n = 1). Out of the 20 clinical samples from osteoarticular TB group, Pab based PCR showed a positive result in 16 clinical samples, and IS6110 PCR showed a positive result in 15 samples [Table 1]. All the 10 control group samples showed a negative result with both tests.
|Table 1: Comprehensive demographic data of all the cases involved in the study|
Click here to view
The sensitivity of IS6110 PCR and Pab PCR were found to be 75% and 80%, respectively, and the specificity of both IS6110 PCR and Pab PCR was 100% [Table 2] and [Table 3]. The difference between the sensitivity of two PCR assays (IS6110 and Pab) was not found to be statistically significant (P > 0.05).
The concordance between two PCRs was calculated using bivariate two-by-two tables. Seventeen out of 20 samples showed concordance between the results of two PCR tests. A moderate agreement between the two methods was found using Kappa statistics (κ = 0.571). There were two cases (10%) which were negative by IS6110 PCR but were positive by Pab PCR. There was one case (5%) which was positive by IS6110 but was negative by Pab PCR. Thus, using both tests, the sensitivity increases to 85%.
| Discussion|| |
TB was declared as a global emergency in 1993 by the World Health Organization (WHO) and still remains a major health problem. It has been estimated that 1%–3% of patients suffering from TB have skeletal involvement. Joint TB occurs most commonly in children and young adults and destroys the joint structure. Early diagnosis and timely institution of antitubercular treatment are thus crucial in these cases, to minimize cartilage destruction.
Accuracy and speed of diagnosis are key factors in the timely management extra-pulmonary tuberculosis (EPTB). The acid-fast bacilli smear examination and radiology have a limited role in the early diagnosis of EPTB. Acid-fast staining requires a large number of bacilli (>10 cells/ml) and culture requires 6–8 weeks, which is often negative due to the small number of bacilli in tissue samples. The newer tests like radiometric BACTEC system also lacks sensitivity and may not be cost effective. The in vitro T-cell based IFN-gamma release assays have limited utility in diagnosis and treatment in highly endemic countries. Serological antibody detection methods have been widely used; however, due to inconsistent and imprecise estimates, the WHO expert group meeting convened in 2010 has strongly recommended against the use of any of these serological tests for the diagnosis of both pulmonary tuberculosis and EPTB. Thus, the definitive diagnosis of EPTB basically depends on histological evidence, which may also be inconclusive, and often needs a high level of expertise for obtaining and confirming tissue diagnosis. A major breakthrough in the diagnosis of EPTB was achieved by the introduction of nucleic acid amplification tests such as PCR to detect nucleotide sequences unique to M. tb in the tissue samples which give results within a few hours. PCR have been reported to be more sensitive and specific; the detection limit of the PCR is 1–10 bacilli in various clinical samples.
The reported sensitivity of the PCR technique in the diagnosis of osteoarticular TB varies from 53% to 100% and the specificity from 63% to 100%. The reasons for the variations in sensitivity in different studies may be due to variability in PCR protocols (use of different PCR primers and methods of extraction), study setting, reference standards and finally on the expertise of the personnel conducting the assay. Various gene targets such as IS6110, 16Sr RNA gene, 65 kDa protein gene, MPB-64 protein gene, 38 kDa protein gene, TRC4, MTP-40 protein gene, and PPE gene have been employed in these PCR assays. It is evident from the published literature that IS6110 is the most widely used PCR assay, the presumed reason being the presence of multiple copies of IS6110 in the M. tb complex, which confers a high sensitivity to the test. However, Das et al. and Yuen et al. reported the existence of a group of M. tb strains that appear to have either one or no copy of IS6110 insertion element. Thus, PCR diagnosis based exclusively on the IS6110 sequence could lead to a significant number of false negative results.
To add to the sensitivity, we evaluated and compared two PCR assays involving two different M. tb specific DNA sequences, i.e., IS6110 and Pab for the diagnosis of osteoarticular TB. Both Pab PCR and IS6110 PCR were individually found to have a higher sensitivity of 80% and 75%, respectively. We confirmed that the positive tests obtained by our PCR study were not false positives by repeating the tests and found them to be positive twice. In addition, we have followed all our patients, and they were found to have a good clinical response to anti-TB chemotherapy thus reconfirming the diagnosis of osteoarticular TB. The study correlated well with a previous study based on Pab PCR test by Sharma et al. who reported 82.8% sensitivity and 100% specificity in tuberculous meningitis samples. We obtained a higher sensitivity compared with a study by Negi et al. who reported 71.5% sensitivity in EPTB samples using the Pab PCR test.
Comparing the efficacy of two different PCR assays, we found no statistically significant difference between them. Negi et al. similarly found no significant difference between the four PCR protocols (IS6110, 38 kDa, 65 kDa and 85B mRNA based PCR) for the early diagnosis of TB in pulmonary and extrapulmonary clinical samples.
The individual sensitivities of IS6110 PCR and Pab PCR were 75% and 80%, respectively. However, the sensitivity of the diagnostic PCR is increased to 85% when both the gene sequences are targeted, instead of only one. This is evident by the concordant results obtained in 17 out of the 20 cases. Thus, we were able to diagnose 10% additional osteoarticular TB cases using “double” PCR assays, which would have been missed otherwise. Since this is a small sample, this may not look significant but may have significant diagnostic implications. Sharma et al. have previously shown that the use of more than one target gene (multiplex PCR) increased the diagnostic yield in paucibacillary conditions like osteoarticular TB. In their study, they performed multiplex PCR using two target genes specific for M. tb namely IS6110 and MPB 64. The sensitivity of IS6110 and MPB64 assays in isolation were 73.75% and 80%. Using multiplex PCR, the sensitivity increased to 82%.
Another finding was that a sample from a case of spine TB, who had already received anti-TB therapy for 4 weeks, showed positive result by PCR test and negative result by culture. This confirmed that the DNA amplification methods could detect even the nonviable mycobacteria, making this an important diagnostic tool in patients who have empirically been started ATT, but the diagnosis remains suspicious and not confirmed.
The main limitations of the PCR tests are false positivity and false negativity. The percentage of false positivity in our study was 0% by both PCR tests, compared to the reported rate in the literature ranging from 3% to 20%. Considering the high detection rates by the PCR test, we suggest that repeating the PCR test after some time may further help to reduce the false negative results due to the extremely low bacilli count in some clinical samples. This would be very beneficial in the early stages of the disease when the diagnosis has yet to be established. Performing PCR targeting two or more different gene sequences in the same clinical sample does not add much to the cost of the test since it requires only additional primers specific for M. tb.
| Conclusion|| |
Using two target genes for PCR in the same sample, the diagnostic accuracy in osteoarticular TB is increased by about 10%, which might be pivotal in clinching an early diagnosis in suspicious cases, especially in endemic areas.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Jambhekar NA, Kulkarni SP, Madur BP, Agarwal S, Rajan MG. Application of the polymerase chain reaction on formalin-fixed, paraffin-embedded tissue in the recognition of tuberculous osteomyelitis. J Bone Joint Surg Br 2006;88:1097-101.
Singh UB, Seth P. PCR diagnosis of tuberculosis – Experience in India. Indian J Pediatr 2002;69 Suppl 1:S20-4.
Dale JW, Tang TH, Wall S, Zainuddin ZF, Plikaytis B. Conservation of IS6110 sequence in strains of Mycobacterium tuberculosis
with single and multiple copies. Tuber Lung Dis 1997;78:225-7.
Das S, Paramasivan CN, Lowrie DB, Prabhakar R, Narayanan PR. IS6110 restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis
from patients with pulmonary tuberculosis in Madras, South India. Tuber Lung Dis 1995;76:550-4.
Yuen LK, Ross BC, Jackson KM, Dwyer B. Characterization of Mycobacterium tuberculosis
strains from Vietnamese patients by Southern blot hybridization. J Clin Microbiol 1993;31:1615-8.
Miyazaki Y, Koga H, Kohno S, Kaku M. Nested polymerase chain reaction for detection of Mycobacterium tuberculosis
in clinical samples. J Clin Microbiol 1993;31:2228-32.
Dolin PJ, Raviglione MC, Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ 1994;72:213-20.
Tuli SM. Tuberculosis of the Skeletal System. 4th
ed. New Delhi: Jaypee Brother Medical Publishers; 2010. p. 4-13.
Jin XB, Sun YS, Zhang K, Wang J, Ju XD, Lou SQ. Neocartilage formation from predifferentiated human adipose derived stem cells in vivo
. Acta Pharmacol Sin 2007;28:663-71.
Brisson-Noël A, Gicquel B, Lecossier D, Lévy-Frébault V, Nassif X, Hance AJ. Rapid diagnosis of tuberculosis by amplification of mycobacterial DNA in clinical samples. Lancet 1989;2:1069-71.
Clarridge JE 3rd
, Shawar RM, Shinnick TM, Plikaytis BB. Large-scale use of polymerase chain reaction for detection of Mycobacterium tuberculosis
in a routine mycobacteriology laboratory. J Clin Microbiol 1993;31:2049-56.
Kolk AH, Schuitema AR, Kuijper S, van Leeuwen J, Hermans PW, van Embden JD, et al.
Detection of Mycobacterium tuberculosis
in clinical samples by using polymerase chain reaction and a nonradioactive detection system. J Clin Microbiol 1992;30:2567-75.
Dyrhol-Riise AM, Gran G, Wentzel-Larsen T, Blomberg B, Haanshuus CG, Mørkve O. Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the Quantiferon-TB gold in-tube assay in outpatients from a tuberculosis low-endemic country. BMC Infect Dis 2010;10:57.
Morris K. WHO recommends against inaccurate tuberculosis tests. Lancet 2011;377:113-4.
Sharma SK, Mohan A. Extrapulmonary tuberculosis. Indian J Med Res 2004;120:316-53.
Mehta PK, Kalra M, Khuller GK, Behera D, Verma I. Development of an ultrasensitive polymerase chain reaction-amplified immunoassay based on mycobacterial RD antigens: Implications for the serodiagnosis of tuberculosis. Diagn Microbiol Infect Dis 2012;72:166-74.
Rattan A. PCR for diagnosis of tuberculosis: Where are we now? Ind J Tub 2000;47:79-82.
Sharma K, Sharma A, Singh M, Ray P, Dandora R, Sharma SK, et al.
Evaluation of polymerase chain reaction using protein b primers for rapid diagnosis of tuberculous meningitis. Neurol India 2010;58:727-31.
] [Full text]
Negi SS, Anand R, Basir SF, Pasha ST, Gupta S, Khare S, et al.
Protein antigen b (Pab) based PCR test in diagnosis of pulmonary and extra-pulmonary tuberculosis. Indian J Med Res 2006;124:81-8.
] [Full text]
Negi SS, Anand R, Pasha ST, Gupta S, Basir SF, Khare S, et al.
Diagnostic potential of IS6110, 38kDa, 65kDa and 85B sequence-based polymerase chain reaction in the diagnosis of Mycobacterium tuberculosis
in clinical samples. Indian J Med Microbiol 2007;25:43-9.
] [Full text]
Sharma K, Sharma A, Sharma SK, Sen RK, Dhillon MS, Sharma M. Does multiplex polymerase chain reaction increase the diagnostic percentage in osteoarticular tuberculosis? A prospective evaluation of 80 cases. Int Orthop 2012;36:255-9.
Sun YS, Lou SQ, Wen JM, Lv WX, Jiao CG, Yang SM, et al.
Clinical value of polymerase chain reaction in the diagnosis of joint tuberculosis by detecting the DNA of Mycobacterium tuberculosis
. Orthop Surg 2011;3:64-71.
[Table 1], [Table 2], [Table 3]